RxDoctor Payments Data

Neal Shah, MD

Internal Medicine · Valhalla, NYNPI 1972985448

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,500 of the $5,299 with a category attached, or 66.1%. Pharmacosmos Therapeutics Inc. accounts for 68.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $3,643 and has fallen 85.3% since, to $534 in 2024. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,299in general payments, 2019–2025

Across 46 payments — averaging $115.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharmacosmos Therapeutics Inc.$4K
  • Pfizer$474
  • Johnson & Johnson$350
  • Boston Scientific$162
  • Steris Corporation$149
  • AstraZeneca$146
  • plus $397 from 6 others
$3,167,996in research payments, 2019–2025

Across 130 payments — averaging $24,369 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exelixis Inc.$3.2M

What the payments were for

  • Speaking & faculty fees$3,50066%
  • Food & beverage$1,79934%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,299 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Medicare billing

Part B allowed, 2024
$43,193
Medicare patients
129
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Valhalla

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →